Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Angirel MR - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Angirel MR

Approved

STANDARD

Angirel MR

Unison Laboratories Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: c546df1e9df96afe
Company: Unison Laboratories Co., Ltd.
Type: Standard

Approval Details

Approval Id: c546df1e9df96afe
Drug Approval Philippines Name: Angirel MR
Product Name: Angirel MR
Registration Number: DR-XY45017
Brand Name: Angirel MR
Generic Name: Trimetazidine Hydrochloride
Dosage Form: Modified-Release Tablet
Dosage Strength: 35 mg
Manufacturer: Unison Laboratories Co., Ltd.
Importer: JustRight Healthcare Inc
Distributor: JustRight Healthcare Inc.
Issuance Date: 28 January 2025
Expiry Date: 22 February 2026
Pharmacologic Category: Anti-Angina
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

c546df1e9df96afe

Type

Standard

Back to Philippines FDA Approvals